Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine fumarate for remyelination in internuclear ophthalmoparesis in multiple sclerosis
2021-003677-66Phase 3Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clemastine in multiple sclerosis (MS) (2 arms), sponsored by Amsterdam University Medical Center. Started Dec 2021; status: active.
02
Drugs
clemastine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2021-003677-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003677-66.